Benefits outweigh VTE risk from acne drug in women, finds EMA
The benefits of an acne drug outweigh its risks of blood clot formation, according to a safety review by European Union experts.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units